Communiqués Collegium Pharmaceutical, Inc.

Actions

COLL

US19459J1043

Produits pharmaceutiques

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 14/07/2026			Varia. 5j.	Varia. 1 janv.
35,02 ^USD	+0,57%		-3,90%	-24,36%

15/05	Collegium Pharmaceutical, Inc. annonce la nomination de Michael Donovan au poste d'administrateur	CI
12/05	Collegium finalise l'acquisition d'Azstarys® auprès de Corium Therapeutics	RE

Communiqués

05/06	Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	GL
27/05	Collegium to Participate in 2026 Jefferies Global Healthcare Conference	GL
12/05	Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics	GL
07/05	Collegium Pharmaceutical : COLL Q1 2026 Earnings Presentation (Pre-Close) FINAL 05-05-26	PU
07/05	Collegium Pharmaceutical: Q1 Earnings Snapshot	AQ
07/05	Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress	GL
23/04	Collegium to Report First Quarter 2026 Financial Results on May 7, 2026	GL
08/04	Collegium to Participate in Upcoming Investor Conferences	GL
08/04	Collegium to Participate in Upcoming Investor Conferences	AQ
20/03	Collegium to Acquire AZSTARYS from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory	AQ
19/03	Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory	GL
19/03	Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory	AQ
05/03	Collegium to Present New Real-World Data at PainConnect 2026	GL
04/03	Collegium Pharmaceutical - Paris Hilton Shares Her Experience with JORNAY PM and Launches New Embrace Your Sparkle, Campaign with Collegium to Empower the ADHD Community	AQ
03/03	Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community	GL
02/03	Collegium to Participate in Upcoming Investor Conferences	GL
26/02	Collegium Pharmaceutical : 25-Q4 - Earnings Presentation FINAL	PU
26/02	Collegium Pharmaceutical: Q4 Earnings Snapshot	AQ
26/02	Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results	GL
23/02	Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical	GL
12/02	Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026	GL
15/01	Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference	GL
08/01	Collegium Provides 2026 Financial Guidance and Business Update	GL
08/01	Collegium Provides 2026 Financial Guidance and Business Update	AQ
30/12	Collegium Announces the Closing of $980 Million Syndicated Credit Facility	GL